Bliss Kelly 4/A

What Happened

• Bliss Kelly, President, U.S. Group Health at Teladoc Health (TDOC), was granted 15,596 performance stock units (PSUs) and reported an exercise/conversion of 5,198 derivative units on Feb 27, 2026. Both transactions are reported with a $0 per-share price (award/derivative conversion, not an open‑market cash sale or purchase).

Key Details

• Transaction dates: reported as Feb 27, 2026 (Form 4 filed as an amendment on Mar 12, 2026; original Form 4 filed Mar 3, 2026 contained an incorrect award amount).
• Grants: 15,596 PSUs @ $0.00 (award/derivative acquisition).
• Exercise/conversion: 5,198 derivative shares @ $0.00 (reported as disposed; no cash proceeds reported).
• Vesting/conditions: PSUs are performance-based (measured against 2025 financial results) and convert one-for-one to common shares. One‑third vests on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
• Shares owned after transaction: not specified in the amended filing.
• Filing status: This is an AMENDED Form 4 correcting the number of PSUs reported in the March 3, 2026 filing.

Context

• These entries are compensation-related derivative transactions (performance stock units) rather than open‑market buys or sales; PSUs reflect contingent rights to receive shares if performance/vesting conditions are met. The exercise/conversion reported at $0 typically reflects conversion/settlement mechanics rather than a paid purchase or an immediate cash sale.